Chemical Bank’s AstraZeneca AZN Stock Holding History

Chemical Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,000	Closed	-$282K	–	333
2014 Q4	$282K	Hold	4,000	–	–	0.04%	283
2014 Q3	$286K	Sell	4,000 -2,000	-33%	-$146K	0.05%	255
2014 Q2	$446K	Hold	6,000	–	–	0.08%	200
2014 Q1	$389K	Hold	6,000	–	–	0.07%	213
2013 Q4	$356K	Hold	6,000	–	–	0.06%	231
2013 Q3	$312K	Hold	6,000	–	–	0.06%	240
2013 Q2	$284K	Buy	+6,000	New	+$306K	0.06%	233

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Chemical Bank's AZN Position: Q1 2015 in Review

Chemical Bank sold out of AstraZeneca (AZN) in Q1 2015, closing a stake of 4,000 shares — an estimated $282K sold.

Chemical Bank first reported a position in AZN in Q2 2013 and held it in 7 quarters. The position peaked at $446K in Q2 2014. 386 funds tracked by Wall St. Rank hold AZN as of Q1 2015.

Chemical Bank reported no remaining AstraZeneca position as of Q1 2015 after selling out during the quarter.
Chemical Bank sold 4,000 AstraZeneca shares in Q1 2015, an estimated $282K.
Chemical Bank first reported a position in AstraZeneca in Q2 2013 and held it in 7 quarters.
Chemical Bank's AstraZeneca position peaked at $446K in Q2 2014.
386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2015.

Based on Chemical Bank's 13F filing for Q1 2015, filed 11 May 2015.